openPR Logo
Press release

Neurostimulation Device Market is estimated to grow at a CAGR of 11.70% during 2018 to 2023 | Vital Players are Aleva Neurotherapeutics SA, St. Jude Medical Inc., Medtronic PLC, Boston Scientific Corporation, LivaNova PLC, Cochlear Ltd.

03-15-2019 08:01 AM CET | Health & Medicine

Press release from: Research Cosmos

/ PR Agency: Research Cosmos
Neurostimulation Device Market is estimated to grow at a CAGR

Neurostimulation Device Market Size and Growth Rate:
Neurostimulation Device Market was valued at USD 3.28 billion in 2016 and projected to reach USD 8.87 billion by 2023 growing at a CAGR of 11.70% during the forecast period 2018 to 2023.

Neurostimulation Device Market Overview:
The global neurostimulation device market is growing at an accelerated rate due to the increasing prevalence of chronic pain, the growth of the geriatric population and the increase in the number of neurological incidents. In addition, the growing awareness of mental illnesses and their treatment also increases the demand for neurostimulation devices.

Browse details of 190 number of pages research report developed on
Neurostimulation Device Market @ https://www.researchcosmos.com/reports/neurostimulation-devices-market-by-product-and-application-global-industry-analysis-and-forecast-t/97971053

Neurostimulation Device Market Growth Drivers and Restraints:
The growth of the neurostimulation device market is related to the increasing prevalence of chronic pain, since it is usually associated with a wide range of injuries and illnesses that last more than a year. Neurostimulation devices help reduce pain by blocking pain signals before they reach the brain. In addition, the increase in the geriatric population strengthens the growth of the market, since the elderly are more sensitive to chronic pain and neurological disorders, such as Alzheimer's disease, epilepsy and Parkinson's disease. In addition, the growing demand for minimally invasive treatments and the increased investment in R & D for the development of new and innovative neurostimulation devices is also increasing their demand. Neurostimulation surgery requires the establishment of minimally invasive procedures compared to other surgeries. In addition, as the prevalence of chronic pain and neurological disorders increases worldwide, the demand for minimally invasive therapies also increases. This has the effect of increasing the demand for new and effective medical technologies, including neurostimulation devices for the treatment of damaged nerves and the relief of chronic pain, thus stimulating the market of neurostimulation devices.

Side effects caused by implanted neurostimulation devices and the high cost of these devices are the main barriers to the market growth. In addition, the availability of other treatment options, including pharmacotherapy and other surgical interventions, is holding back the market growth of these devices.Neurostimulation devices are having wide range of applications in Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease, and Others.

Geographic Insights of Neurostimulation Device Market:
Geographically, North America has the largest share in the global market for neurostimulation devices and is expected to remain the largest market during the forecast period. The North American market is growing due to the increasing prevalence of neurological disorders and the growth of the geriatric population in the region. In addition, the increasing incidence of chronic pain is also driving the market growth in this region. Among the countries of North America, the market in the United States is the largest and is expected to have a market share of 82% by 2022.

Ask Free Sample of the report @ https://www.researchcosmos.com/request/neurostimulation-devices-market-by-product-and-application-global-industry-analysis-and-forecast-t/97971053

Key Market Players of Neurostimulation Device Market:
Some of the prominent players of the market include Aleva Neurotherapeutics SA, St. Jude Medical Inc., Medtronic PLC, Boston Scientific Corporation, LivaNova PLC, Cochlear Ltd., Neuropace Inc., Neurosigma Inc., MED-EL GmbH, Synapse Biomedical Inc., Neuronetics Inc., NDI Medical LLC, EnteroMedics Inc., and ImThera Medical.

Neurostimulation Device Market Key Segmentation:

By Product:
• Deep Brain Stimulator
• Sacral Nerve Stimulator
• Spinal Cord Stimulator
• Gastric Electric Stimulator
• Vagus Nerve Stimulator

By Application:
• Epilepsy
• Urinary and Fecal Incontinence
• Dystonia
• Parkinson's Disease
• Pain Management
• Essential Tremor
• Depression
• Gastroparesis
• Others

By Region:
• North America
• South America
• Europe
• Asia Pacific
• Middle East and Africa

For any queries, inquire more @ https://www.researchcosmos.com/inquire/neurostimulation-devices-market-by-product-and-application-global-industry-analysis-and-forecast-t/97971053

About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurostimulation Device Market is estimated to grow at a CAGR of 11.70% during 2018 to 2023 | Vital Players are Aleva Neurotherapeutics SA, St. Jude Medical Inc., Medtronic PLC, Boston Scientific Corporation, LivaNova PLC, Cochlear Ltd. here

News-ID: 1656124 • Views:

More Releases from Research Cosmos

Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
Mobile Phone Insurance Market Size to Reach USD 32.24 Bn By 2025
The size of the Global mobile phone insurance market is estimated to reach USD 32.24 billion by 2025, growing at a CAGR of 12.5%, as per the recently published report by Research Cosmos. It is worth to claim insurance for mobile phones as we are spending a lot of money on purchasing. The policies include accidental damage, water damage, and screen cracking. Browse details of the report @ https://www.researchcosmos.com/reports/mobile-phone-insurance-market/199557834 Growing utilization
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By 2025 | Leading Market Players - Kudos, Achievers Corp., REFFIND Ltd., Globoforce, Terryberry, Ultimate Software, Peoplecart, CorporateRewards
Social Employee Recognition Systems Market Predicted to grow at a CAGR of xx By …
Social Employee Recognition Systems Market Analysis Size, Growth rate and Overview: Social Employee Recognition Systems Market was valued at USD xx million in 2018 and is expected to reach almost USD xx million by the end of 2025, growing at a CAGR of around xx% over the predicted period. Throughout the world, social employee recognition systems have expanded dramatically to address the need to move away from traditional methods and programs of

More Releases for Neurostimulation

Neurostimulation Devices Market Size Report 2032 | DelveInsight
DelveInsight's Neurostimulation Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading companies' market shares, challenges, Market Drivers, barriers, trends, and key Neurostimulation Devices companies in the market. To read more about the latest highlights related to the Neurostimulation Devices Market, get a snapshot of the key highlights entailed in the Market Report @ Neurostimulation Devices Market Size- https://www.delveinsight.com/sample-request/neurostimulation-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Neurostimulation Devices Market Report • The
Neurostimulation Devices Market: Unlocking Solutions for Neurological Disorders
In recent years, the global Neurostimulation Devices Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neurostimulation Devices Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
Internal Neurostimulation Devices Market - Igniting the Power Within: Internal N …
Newark, New Castle, USA: The "Internal Neurostimulation Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Internal Neurostimulation Devices Market: https://www.growthplusreports.com/report/internal-neurostimulation-devices-market/8803 This latest report researches the industry structure,
Neurostimulation Systems Market 2021 | Detailed Report
The research reports on “Neurostimulation Systems Market” report gives detailed overview of factors that affect global business scope. Neurostimulation Systems Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC,
Mainstay Medical Announced the Launch of Reactiv8 Implantable Restorative Neuros …
The growing prevalence of Parkinson’s disease is projected to propel the growth of the neurostimulation devices market. According to the Parkinson's Foundation, around 1 million people in the U.S. will suffer from Parkinson's disease by 2020. It also reports that around 60,000 Americans are diagnosed with Parkinson's disease each year. The Parkinson's Foundation also estimates that 1.2 million people in the U.S. are expected to develop Parkinson's disease by 2030.
Neurostimulation Devices Market Revenue Forecast 2020-2026
Neurostimulation Devices Market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability. The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market. The neurostimulation devices market is projected to garner significant growth on account of rising cases of neurological disorders and proliferating demand